Is XLV a Buy? What to Consider in 2026
Short answer
There is no one-size answer, and Walnut is not an investment adviser. XLV (Health Care Select Sector SPDR Fund) tracks Health Care Select Sector at a 0.08% expense ratio. Whether it is a buy for you comes down to four things: do you want what it holds, is the cost competitive, do you already own it through another fund, and does it fit your time horizon. This page lays out the case for, what to weigh, and a framework to decide.
What are you buying with XLV?
Tracks the healthcare sector of the S&P 500: large US pharmaceutical, biotech, managed-care, medical device, and life-science companies. A defensive sector tilt rather than a broad-market core, often less correlated with technology than the overall index. Verify current figures on the issuer's site.
Largest holdings (approximate as of early 2026; verify on State Street SPDR's fund page):
What's the case for XLV?
XLV is the Health Care Select Sector SPDR Fund, a fund that tracks the healthcare sector of the S&P 500 at a 0.08% expense ratio. It holds the large US pharma, biotech, insurer, device, and equipment companies (LLY, UNH, JNJ), so it is a sector bet on healthcare rather than a broad-market core. Versus VOO, XLV strips out everything except healthcare, which makes it more defensive and less tech-driven than the overall market.
In its favour: it gives you Health Care Select Sector exposure in one ticker at a 0.08% expense ratio, which is simple to hold and cheap to own.
What should you weigh before buying XLV?
- Cost vs alternatives: 0.08% is the fee; compare it to funds tracking a similar index.
- Concentration: check how much of XLV sits in its largest holdings (LLY, UNH, JNJ).
- Overlap: if you already own a broad-market fund, you may already hold much of this.
- Tracking scope: XLV only gives you Health Care Select Sector; it will not capture what sits outside that index.
How do you decide if XLV is a buy?
The useful question is rarely “will XLV go up?” It is “does this exposure fit my plan, at a cost I am happy with, without doubling up on what I already own?” Walnut connects your real brokerage so you can see exactly how XLV would overlap with your current holdings, analyze it by chatting through Claude or ChatGPT, and place any trade yourself. You stay in control.
The bottom line on XLV
Whether XLV is a buy is not a universal verdict: it tracks Health Care Select Sector at 0.08%, so it is a buy for you only if you want that exposure, the cost is competitive, and you do not already own most of it through another fund. Decide from your goal and your existing holdings, not from where the market sat last week. Walnut is not an investment adviser.
Build a portfolio around XLV with Walnut
Use XLV as your core holding, then let Walnut's AI propose thematic satellites: AI infrastructure, dividend growth, clean energy, whatever you believe in. Connect your broker, build the basket in conversation, track it as one unit.
FAQ
Is XLV a good ETF to buy?
+
Walnut is informational, not investment advice. Whether XLV fits depends on your goals, time horizon, and what you already hold. It tracks Health Care Select Sector at a 0.08% expense ratio, so the questions that matter are whether you want that exposure, whether you already own it through another fund, and whether the cost is competitive for what it does.
What does XLV actually hold?
+
XLV tracks Health Care Select Sector. Its largest positions include LLY, UNH, JNJ, ABBV, MRK and others (approximate, verify on State Street SPDR's fund page). The holdings are what you are really buying, not the ticker.
What is XLV's expense ratio?
+
0.08% as of early 2026. Over decades, the expense ratio is one of the few things you can control, so it is worth comparing against close alternatives that track a similar index.
Does XLV pay a dividend?
+
XLV distributes a dividend with an approximate yield of ~1.6% (early 2026). See the XLV dividend page for how distributions work. Verify the current figure with State Street SPDR.
What are the risks of buying XLV?
+
Like any index ETF, weigh concentration (how much sits in the top holdings), overlap with funds you already own, and whether Health Care Select Sector matches the exposure you actually want. XLV only gives you Health Care Select Sector, not what sits outside it.
How do I decide if XLV is right for me?
+
Start from your goal, then check four things: what XLV holds, its cost versus alternatives, how much it overlaps with what you already own, and whether the exposure fits your time horizon and risk tolerance. Walnut can analyze the overlap against your real holdings; you keep your broker and approve any trade.
Walnut is informational, not investment advice. Figures are approximations stamped to early 2026; verify current data with State Street SPDR or your broker. Nothing here is a recommendation to buy, sell, or hold any security.